Ebola Fear Funding Crisis

Executive summary

A fast-moving Ebola outbreak in the Democratic Republic of the Congo — caused by a strain with no licensed vaccine or treatment — has collided with COVID-scarred public psychology, producing alarm levels that far outpace the actual risk most Americans face. Three in four U.S. respondents (75.2%) say they are concerned about the outbreak, and their open-ended answers are saturated with pandemic memory: "not another COVID," "here we go again," "PTSD from COVID."

The survey of 202 adults, fielded as WHO declared a Public Health Emergency of International Concern on May 17, 2026, captures a public that is simultaneously anxious and generous. Nearly two-thirds (63.9%) say wealthy countries have a global responsibility to fund outbreak responses in developing nations — even as a measurable undercurrent of distrust runs through their views of the international health institutions that would execute that response.

Four things stand out: public concern is real but misframed by COVID memory; the Bundibugyo strain's lack of countermeasures makes the pessimism about containment scientifically grounded; the U.S. funding retreat is already straining WHO's emergency reserves; and empathy — not institutional loyalty — is the primary engine driving support for global aid.

Context

The DRC Ebola outbreak making headlines in late May 2026 is not a replay of prior crises — it is a harder one. The culprit is Bundibugyo ebolavirus (BDBV), a strain first identified in Uganda in 2007 that has never produced a licensed vaccine or approved treatment. That distinguishes it sharply from the Zaire strain that drove the devastating 2014–2016 West Africa epidemic and the 2018–2020 DRC outbreak, both of which eventually benefited from ring-vaccination campaigns. There is no ring vaccination available here.

By May 26, 2026, ECDC tallied 105 confirmed cases and 906 suspected cases across Ituri, North Kivu, and South Kivu provinces, with 7 confirmed cases already recorded in Uganda. WHO declared a PHEIC on May 17; Africa CDC followed a day later with a Public Health Emergency of Continental Security. WHO's regional director called it "a big mistake to underestimate" a virus for which no vaccine exists.

The operational environment amplifies the biological challenge. Eastern DRC is one of the world's most active conflict zones. Nearly 10 million people in the affected provinces face acute hunger. Health facilities are either non-functional or severely constrained by insecurity. A 2019 PLOS ONE study of 630 community respondents in eastern DRC found that 72% were mistrustful of Ebola response efforts, and current field reports document treatment centers being torched — a pattern that has recurred across multiple DRC outbreaks.

Layered on top of all this is a funding crisis. WHO's Contingency Fund for Emergencies had received just $5.4 million in donor contributions in 2026 and had already deployed nearly $4 million of that on this outbreak alone. U.S. pledges for the next five-year period represent a 27% cut compared to the prior cycle, and the dissolution of USAID has already forced partner organizations to fire staff and halt Ebola-focused activities in both DRC and Uganda.

This survey — 202 U.S. adults, fielded in the days surrounding the PHEIC declaration — offers a real-time read on how the American public is processing a crisis that experts describe as geographically distant but structurally consequential.

Findings

COVID's shadow makes every outbreak feel like a pandemic

Seven in ten Americans (75.2%) express concern about the DRC Ebola outbreak — a number that looks proportionate until you consider what WHO and ECDC are actually saying. Both agencies rate global risk as low. The average American faces no meaningful personal exposure from a bodily-fluid-transmitted virus circulating in conflict-affected provinces of eastern DRC. Yet free-response answers in this survey skew firmly toward the anxious end of the emotional spectrum, with a mean score of –0.26 on a scale where –1 represents "highly anxious or fearful" and +1 represents "calm and curious."

Dr. Amesh Adalja of Johns Hopkins put it plainly in an NPR interview: "The nuances of the biology of different pathogens, the trajectories of different outbreaks, that all gets lost because what people are worried about is having a disruptive event like COVID upend their entire life." Content creator Chandra Harvey, whose language mirrors survey respondents, said simply: "We're all dealing with PTSD from COVID."

The result is a perception-reality gap that has real consequences. Misplaced fear can fuel stigma, overwhelm public health communicators, and crowd out accurate information about genuine risks — including the Bundibugyo strain's lack of countermeasures, which deserves serious attention on its own terms.

The Bundibugyo strain gives the pessimists scientific cover

Respondents' open-ended answers lean toward expecting the outbreak to spread unchecked, with a mean score of +0.20 on a containment confidence scale (where +1 = "will spread unchecked"). That pessimism is not unfounded. ECDC's May 21 threat assessment states plainly: "There are currently no licensed vaccines or specific treatments available for BDBV disease." That single sentence separates this outbreak from every major Ebola response of the past decade.

The case count reflects it. Starting from fewer than 750 suspected cases when WHO elevated risk to "very high," the outbreak had crossed 1,000 total cases within days. Spread has reached 11 health zones. Uganda has recorded confirmed cases. WHO's own emergency committee acknowledged the epidemic is unfolding "in one of the most challenging operational environments possible" — active armed conflict, collapsed health infrastructure, and deep community resistance including the burning of a treatment center the day before WHO's risk elevation.

A prior CDC study of the strain's 2007–2008 emergence found a case-fatality rate of 34%, lower than Zaire ebolavirus but still lethal at scale. The combination of no countermeasures, active conflict, and 10 million people facing acute hunger in affected provinces means respondents who lean toward "will spread unchecked" are tracking reality more closely than those who aren't paying attention at all.

Most people want to help — but not because they trust WHO

The most consequential finding in this data is a paradox: 63.9% of respondents say wealthy countries have a global responsibility to fund outbreak responses in developing nations, even though free-response answers show a slight but statistically significant lean toward distrust of official health narratives (mean +0.06 on a scale where +1 = distrust).

In other words, support for collective action is not downstream of institutional faith. It is decoupled from it. Respondents who rated international health organizations with low trust scores were still more likely to answer "Yes, it's a global responsibility" — a finding that holds at moderate-to-high confidence across 129 respondents with trust data. Only 13.9% said countries should handle their own problems. Another 17.8% conditioned support on direct threat to their own citizens.

The Pew Research Center, in January 2025 data, found that 38% of Americans say the U.S. does not benefit much or at all from WHO membership — a steep drop from the 55% who said WHO was doing a good job during COVID. Yet even against that backdrop, the altruistic impulse holds in this survey. The implication for policymakers and advocates is significant: the case for global health funding does not need to rehabilitate WHO's image first. It needs to speak to moral obligation directly.

Empathy, not ideology, drives who supports global aid

The strongest personality signal in the data is agreeableness. Respondents scoring higher on the OCEAN Agreeableness trait are significantly more likely to support wealthy-country funding (r = 0.341) and significantly more likely to express concern about the outbreak (r = –0.324, reflecting greater concern on the concern scale). Both correlations are statistically robust.

The funding correlation is more than twice the size of the meta-analytic benchmark for agreeableness and charitable giving (r = 0.14, from a 2025 Journal of Personality and Social Psychology meta-analysis of the Big Five and philanthropy). The gap suggests that crisis context amplifies prosocial personality effects beyond baseline charitable behavior — when an outbreak is framed as a humanitarian emergency, empathetic people don't just lean toward generosity, they lean harder.

A secondary but meaningful signal: higher Prism Resilience scores are negatively associated with trust in international health organizations (r = –0.235). People who feel confident in their own coping capacity tend to distrust external experts. This is a communications challenge. The most self-reliant individuals — often community opinion leaders — are the hardest to reach through institutional messaging. Outreach that emphasizes personal agency ("here's what your community can do") rather than deference to centralized authorities is likely to resonate more with this segment.

Conclusion

Three things are converging right now: a genuinely dangerous outbreak with no medical countermeasures, a public primed by COVID to expect the worst, and a funding architecture that the U.S. has visibly stepped back from. The 63.9% of Americans who believe wealthy countries share a global responsibility to fund outbreak responses are expressing a mandate that current U.S. policy does not reflect.

The immediate watch items are case trajectory and geographic spread. If Bundibugyo ebolavirus continues to expand across health zones in eastern DRC and into Uganda without licensed countermeasures, respondents' pessimism about containment will look prescient rather than COVID-conditioned. The WHO emergency fund's near-depletion means the next funding gap could translate directly into operational gaps — fewer contact tracers, fewer isolation facilities, fewer community liaisons in zones where 72% of residents already distrust the response.

For communicators, the actionable signal is this: public support for global health action runs ahead of public trust in global health institutions. Campaigns that lead with shared humanity and moral obligation — rather than WHO's credibility — have a receptive audience. Reaching the resilient skeptics requires a different frame: personal agency, community preparedness, and local impact over institutional deference. The anxiety is real; the question is whether it gets channeled into informed solidarity or paralyzed withdrawal.